Commonwealth Fund May 7, 2020
Toplines
COVID-19 is testing the U.S. health care system, and the nation’s generic drug supply chain is no exception
Our lean drug supply chain leaves little room for error when disaster strikes
COVID-19 is testing our health care system in new ways — raising concerns about equity, surge capacity, the social safety net, and data collection. The drug supply chain is no exception. Drug shortages — particularly for generic drugs — are nothing new. But several factors are now straining our supply chain, leading to an increased chance of shortages and exposing risks.
On the demand side, there has been a run on drugs that has led to shortages at the pharmacy counter. Even among drugs...
Today's Sponsors
Today's Sponsor